Leo Qian, PhDCo-Founder and Vice President, Discovery Research at Entrada TherapeuticsSpeaker
Profile
Ziqing “Leo” Qian, Ph.D. is co-founder and Vice President, Discovery Research at Entrada Therapeutics, a Boston-based biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular therapeutics. Dr. Qian co-invented Entrada’s Endosomal Escape Vehicle (EEV™) platform, which is applied to the design and development of intracellular delivery of otherwise impermeable biological cargos, including oligonucleotides, proteins, and peptides. Leo obtained his Ph.D. in Organic Chemistry from The Ohio State University. He has co-authored over 30 peer-reviewed publications and two book chapters, as well as co-inventor on over 10 patents.
Agenda Sessions
Optimization and Application of Endosomal Escape Vehicle (EEV™) Cell-Penetrating Peptides for Enhanced Delivery of Oligonucleotides and Genomic Medicines
, 11:45amView Session